BMS-824393

DRUG2 trials

Sponsors

Bristol-Myers Squibb

Conditions

Chronic Hepatitis CChronic Hepatitis C Virus Genotype 1

Phase 1

Multiple Dose Study In Treatment Naive Subjects Infected With Hepatitis C Virus

CompletedNCT00971308

Bristol-Myers SquibbChronic Hepatitis C

Start: 2009-10-31End: 2010-08-31Updated: 2011-01-25

Phase 2

A Study of BMS-824393 in Combination With Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) in Treatment Naive Subjects With Chronic Hepatitis C Virus Genotype I

WithdrawnNCT01142700

Bristol-Myers SquibbChronic Hepatitis C Virus Genotype 1

Start: 2010-07-31End: 2010-12-31Updated: 2011-03-15